Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy

Juan Zhen,Xia Sheng,Tianlong Chen,Haitao Yu
DOI: https://doi.org/10.1038/s41419-024-06771-x
2024-06-11
Cell Death and Disease
Abstract:Diabetic cardiomyopathy (DCM) is a prevalent myocardial microvascular complication of the myocardium with a complex pathogenesis. Investigating the pathogenesis of DCM can significantly contribute to enhancing its prevention and treatment strategies. Our study revealed an upregulation of lysine acetyltransferase 2 A (Kat2a) expression in DCM, accompanied by a decrease in N6-methyladenosine (m6A) modified Kat2a mRNA levels. Our study revealed an upregulation of lysine acetyltransferase 2 A (Kat2a) expression in DCM, accompanied by a decrease in N6-methyladenosine (m6A) modified Kat2a mRNA levels. Functionally, inhibition of Kat2a effectively ameliorated high glucose-induced cardiomyocyte injury both in vitro and in vivo by suppressing ferroptosis. Mechanistically, Demethylase alkB homolog 5 (Alkbh5) was found to reduce m6A methylation levels on Kat2a mRNA, leading to its upregulation. YTH domain family 2 (Ythdf2) played a crucial role as an m6A reader protein mediating the degradation of Kat2a mRNA. Furthermore, Kat2a promoted ferroptosis by increasing Tfrc and Hmox1 expression via enhancing the enrichment of H3K27ac and H3K9ac on their promoter regions. In conclusion, our findings unveil a novel role for the Kat2a-ferroptosis axis in DCM pathogenesis, providing valuable insights for potential clinical interventions.
cell biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the pathogenesis of diabetic cardiomyopathy (DCM), especially to explore the role of histone acetyltransferase Kat2a in DCM and its mechanism of regulating ferroptosis by enhancing the expression of transferrin receptor (Tfrc) and heme oxygenase 1 (Hmox1). Specifically, the study reveals: 1. **Changes in Kat2a expression in DCM**: The study found that in DCM, the expression of Kat2a is up - regulated, while the level of its m6A - modified mRNA is decreased. 2. **The impact of Kat2a on ferroptosis**: Functional experiments show that inhibiting Kat2a can effectively alleviate high - glucose - induced cardiomyocyte injury, which is mainly achieved by inhibiting ferroptosis. 3. **Regulatory mechanisms**: - **The role of demethylase Alkbh5**: Alkbh5 reduces the m6A methylation level on Kat2a mRNA, leading to the up - regulation of Kat2a expression. - **The role of m6A - reading protein Ythdf2**: Ythdf2 plays a key role in the degradation of m6A - modified Kat2a mRNA. - **Kat2a promotes the expression of Tfrc and Hmox1 by enhancing H3K27ac and H3K9ac**: Kat2a promotes their expression by enhancing histone acetylation in the promoter regions of these genes, thereby exacerbating ferroptosis. In summary, this study aims to clarify the role of Kat2a in DCM and the specific mechanism by which it regulates ferroptosis, providing new ideas for the prevention and treatment of DCM.